Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 311 of the 317 references it cites were found in a registry or an index; 172 of the 310 sources its claims cite were checked for support.

Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment

Open access

Abstract

Despite recent advances in the treatment of obesity, lifestyle medicine remains foundational to the treatment of individuals with obesity, regardless of the modality chosen by the patient with the guidance of the clinician they are working with, including in conjunction with, as appropriate, anti-obesity medications and metabolic surgery. Lifestyle medicine involves the use of diet, exercise, sleep, stress, and other lifestyle modalities in the treatment of disease. Clinicians and health systems should, after a patient-centered discussion with the patient, do their best to ensure access to lifestyle treatments. Gold standard guidelines recommend intensive, multicomponent lifestyle change programs for obesity treatments with evidence-based diet and exercise counseling and established, theoretically driven behavior change components. Clinicians treating obesity should be aware of their own biases, make efforts to reduce stigmatizing experiences in their practice, and address weight stigma in their treatment plans as needed. A variety of dietary patterns can be used to support patients with obesity, and clinicians should make evidence-based but patient-centered recommendations that aim to maximize adherence. Diet and exercise can play an important role in reducing the side effects of treatment and optimizing outcomes in weight loss, attenuating the effects of metabolic adaptation, and weight maintenance. Exercise should be increased gradually to reduce injury with a goal of 200–300 min (approximately 3.3–5 h) of moderate to vigorous intensity exercise per week to maximize weight maintenance effects with exercise prescriptions customized to patients risks. A variety of practice models can be leveraged along with the use of an interdisciplinary team to provide lifestyle medicine care for those with obesity.

Overview

CoChat Summary

TL;DR

This narrative review argues that lifestyle medicine remains foundational to obesity treatment even in the era of highly effective anti-obesity medications and metabolic surgery, and provides a clinically actionable framework covering nutrition, exercise, behavior change, sleep, stress, and stigma reduction. It emphasizes that lifestyle intervention should be offered alongside, not withheld before, pharmacotherapy or surgery, and that multidisciplinary care models are needed to improve access.

Key findings

  • Lifestyle intervention alone produces clinically significant weight loss of 5–10% of initial body weight, with large studies and RCTs averaging 4–6%; patients needing more weight loss may require medications or surgery.
  • The Diabetes Prevention Program showed a 58% risk reduction in developing type 2 diabetes over 2.8 years in patients with overweight/obesity and prediabetes; the DPP Outcomes Study showed protection from diabetes progression despite weight regain.
  • Pairing medication with intensive lifestyle intervention may improve outcomes: the MODEL-IBT study produced close to 12% weight loss with liraglutide plus intensive behavioral therapy (vs. 6–8% average in liraglutide trials), and SURMOUNT-3 showed 25% weight loss with tirzepatide in patients who had already achieved ≥5% weight loss with intensive lifestyle intervention.
  • Exercise targets: 200–300 min/week of moderate-to-vigorous activity to maximize weight maintenance; 225–420 min/week of aerobic activity for meaningful weight and adiposity loss; >150 (preferably up to 250–300) min/week to prevent weight regain. Fat-free mass loss from GLP-1 RA medications is estimated at 25–40% of total weight loss, motivating protein intake and resistance training.

Methods

  • Narrative/expert review intended for primary care clinicians, lifestyle medicine practitioners, and obesity specialists; the authors state it is grounded in current guidelines and provides summary tables and patient-centered strategies.
  • No systematic search strategy, inclusion criteria, or formal evidence appraisal is described; the paper synthesizes guideline statements, RCTs, cohort studies, and mechanistic literature across sections on diet, exercise, sleep, stress, stigma, medications, surgery, and care delivery models.
  • Rarer causes of obesity (monogenic, syndromic, hypothalamic) are explicitly stated to be out of scope.

Limitations

  • Stated: the review is narrative and non-systematic; rarer obesity causes are excluded; several recommendations are explicitly labeled as the authors' experience or position rather than evidence (e.g., fiber for GLP-1 RA side effects, self-monitoring suggestions, inclusive "movement" terminology).
  • Stated: evidence gaps are acknowledged in several areas — little evidence to guide physical activity counseling that reduces stigma, unclear weight-loss outcomes for shared medical appointments, limited research on NEAT interventions for weight maintenance, and unclear long-term benefits/safety of fasting-mimicking diets.
  • Evident from the text: no formal risk-of-bias assessment or quantitative synthesis is performed, and many cited sources are guidelines, prior reviews, and small or single trials, so effect estimates are reported as cited rather than independently verified.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu17142382

Cites

311 of 311 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Lifestyle medicine interprofessional care team.
Figure 1 Lifestyle medicine interprofessional care team.CC BY · PubMed Central

Verification

Claims the paper makes

118 Valid · 6 Not valid · 53 Not checked · 20 Own results and interpretations

109 more claims · 62 with their cited sources checked

Create a free account to see all 197 claims and to verify the 2 references still open.

See all claims — free account
  • It may state two separate claims as one. 65
  • Probably not a substantial claim. 21

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 317 references

Research works printed but not linked: 4

  1. Farhana, A., and Rehman, A. (2025, March 28). Metabolic Consequences of Weight Reduction, StatPearls, Available online: http://www.ncbi.nlm.nih.gov/books/NBK572145/.
  2. Hui, C., and Bauza, G.J. (2025, April 12). Dumping Syndrome, StatPearls, Available online: http://www.ncbi.nlm.nih.gov/books/NBK470542/.
  3. Hoelscher, D.M., Tobias, D., Deierlein, A., Gardner, C., Giovannucci, E., Anderson, C.A.M., Booth, S., Raynor, H., Fung, T., and Stanford, F.C. (2025, June 29). Dietary Patterns and Growth, Body Composition, and Risk of Obesity: A Systematic Review, Available online: https://www.ncbi.nlm.nih.gov/books/NBK611726/.
  4. IQWiG (2025, June 09). In brief: Physical therapy, InformedHealth.org [Internet], Available online: https://www.ncbi.nlm.nih.gov/books/NBK561514/.

Cited by

See all 29

Metadata

Authors
Sannidhi, D., Abeles, R., Andrew, W., Bonnet, J. P., Vitale, K., Niranjan, V., Gulati, M., Pauly, K., Moran, R., Alexander, L., Le, C., Rajan, S., & Romero, C.
Affiliations
  • University of California San Diego (US)
  • Stanford Medicine (US)
  • UC San Diego Health System (US)
  • UConn Health (US)
  • Department of Practice Management, American College of Lifestyle Medicine, Chesterfield, MO 63006, USA
  • Department of Clinical Services, Enara Health, San Mateo, CA 94403, USA
  • San Diego State University (US)
Corresponding author
Sannidhi, Deepa
Venue
Nutrients
Publisher
MDPI AG
Published
2025-07-21
Volume
17
Issue
14
Pages
2382
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4412526707
Cited by
29
References
317
Citations by year
2026: 27 · 2025: 2
FWCI
2.92
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Ardmore Institute of Health
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
Keywords
lifestyle medicine, obesity, anti-obesity drugs, metabolic surgery, nutrition counseling, exercise prescription, weight maintenance, weight loss, weight cycling, metabolic adaptation, weight stigma, behaviour change interventions, patient-centered care, dietary habits, sleep, stress, multidisciplinary care, access barriers
MeSH terms
Healthy Lifestyle, Obesity Management, Diet, Reducing, Humans, Obesity, Patient Care Team, Patient Compliance, Exercise, Patient-Centered Care, Anti-Obesity Agents, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment. https://app.cochat.ai/papers/10.3390/nu17142382
The paper
Sannidhi, D., Abeles, R., Andrew, W., Bonnet, J. P., Vitale, K., Niranjan, V., Gulati, M., Pauly, K., Moran, R., Alexander, L., Le, C., Rajan, S., & Romero, C. (2025). Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment. Nutrients. https://doi.org/10.3390/nu17142382

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.